Matches in Wikidata for { <http://www.wikidata.org/entity/Q100476670> ?p ?o ?g. }
Showing items 1 to 39 of
39
with 100 items per page.
- Q100476670 description "article scientifique publié en 2020" @default.
- Q100476670 description "artículu científicu espublizáu n'ochobre de 2020" @default.
- Q100476670 description "im Oktober 2020 veröffentlichter wissenschaftlicher Artikel" @default.
- Q100476670 description "scientific article published on 05 October 2020" @default.
- Q100476670 description "wetenschappelijk artikel" @default.
- Q100476670 description "наукова стаття, опублікована 5 жовтня 2020" @default.
- Q100476670 name "[Long-term efficacy and safety of etelcalcetide in hemodialysis patients with severe secondary hyperparathyroidism]" @default.
- Q100476670 name "[Long-term efficacy and safety of etelcalcetide in hemodialysis patients with severe secondary hyperparathyroidism]" @default.
- Q100476670 name "[Long-term efficacy and safety of etelcalcetide in hemodialysis patients with severe secondary hyperparathyroidism]" @default.
- Q100476670 type Item @default.
- Q100476670 label "[Long-term efficacy and safety of etelcalcetide in hemodialysis patients with severe secondary hyperparathyroidism]" @default.
- Q100476670 label "[Long-term efficacy and safety of etelcalcetide in hemodialysis patients with severe secondary hyperparathyroidism]" @default.
- Q100476670 label "[Long-term efficacy and safety of etelcalcetide in hemodialysis patients with severe secondary hyperparathyroidism]" @default.
- Q100476670 prefLabel "[Long-term efficacy and safety of etelcalcetide in hemodialysis patients with severe secondary hyperparathyroidism]" @default.
- Q100476670 prefLabel "[Long-term efficacy and safety of etelcalcetide in hemodialysis patients with severe secondary hyperparathyroidism]" @default.
- Q100476670 prefLabel "[Long-term efficacy and safety of etelcalcetide in hemodialysis patients with severe secondary hyperparathyroidism]" @default.
- Q100476670 P1433 Q100476670-3F68A5BD-25DF-4ED3-9293-358C9C8867F5 @default.
- Q100476670 P1476 Q100476670-C3B5238E-DCB5-40A9-904D-42B0A0F91370 @default.
- Q100476670 P2093 Q100476670-9C865751-DE55-4D88-93E9-67C89EC00F6E @default.
- Q100476670 P2093 Q100476670-D146DD0F-B5A5-4440-862D-D333206D6FC9 @default.
- Q100476670 P2093 Q100476670-D3766C8D-1561-4586-B467-64146D0DC866 @default.
- Q100476670 P31 Q100476670-AB67414E-3F92-43D2-9C46-6560247EAB15 @default.
- Q100476670 P433 Q100476670-C7D230AA-9548-44A6-8A22-E9DB33EE3938 @default.
- Q100476670 P478 Q100476670-3262D0FD-1A97-453A-AD7F-5560815DA4F1 @default.
- Q100476670 P577 Q100476670-B632D7B4-1A94-4EE0-877D-9757A355D7F8 @default.
- Q100476670 P698 Q100476670-D7C722F6-EFD3-498E-B908-ADECD86F9088 @default.
- Q100476670 P921 Q100476670-8A1ABED3-8186-4BF2-92EB-883D475BAB29 @default.
- Q100476670 P698 33026204 @default.
- Q100476670 P1433 Q27719255 @default.
- Q100476670 P1476 "[Long-term efficacy and safety of etelcalcetide in hemodialysis patients with severe secondary hyperparathyroidism]" @default.
- Q100476670 P2093 "Carlo Massimetti" @default.
- Q100476670 P2093 "Marco Tondo" @default.
- Q100476670 P2093 "Sandro Feriozzi" @default.
- Q100476670 P31 Q13442814 @default.
- Q100476670 P433 "5" @default.
- Q100476670 P478 "37" @default.
- Q100476670 P577 "2020-10-05T00:00:00Z" @default.
- Q100476670 P698 "33026204" @default.
- Q100476670 P921 Q3622611 @default.